The Valley Desk

ArticleThe journal of pediatrics: XPublished

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
The journal of pediatrics: X
Published
Subject terms
Children; Treatment; Cardiovascular disease; Endothelin receptor antagonist; Clinical Trial
PubMed ID
37332660
PubMed Central ID
PMC10236545
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal